Our lead candidate is a multifaceted attack antibody for ovarian cancer. Our approach enables targeting primary cancer cells directly, alongside enabling the immune system's natural anti-cancer function, all with one therapeutic antibody.
As a full-time founder at Tradewind, my focus is on translating novel science into viable and novel therapeutic approaches and relating the value of our mission. This calls on skills and knowledge developed through 25 years of cancer research experience and more recent experience in business oriented rolls. Skills/Experience - PhD level cancer biologist - Management of a research team - Patent portfolio management and IP agreements - Scientific data analysis and interpretation